Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

Neurology

Adjuvants, Immunologic, Treatment Failure, Retrospective Studies, therapeutic use, administration & dosage, Peptides, drug therapy, Multiple Sclerosis, Middle Aged, Male, adverse effects, Interferon-beta, Injections, Subcutaneous, Injections, Intramuscular, Humans, Female, etiology, Drug-Induced Liver Injury, Drug Utilization, Drug Administration Schedule, Culture, Adult, Adolescent

Read this article at

ScienceOpenPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      A retrospective chart review of patients in British Columbia with multiple sclerosis prescribed beta-interferon (IFNbeta) between 1995 and 2001 was carried out to investigate reasons for the interruption of therapy. The highest proportion of interruptions (76/281; 27%) occurred in the first 6 months. The single most common reason was perceived lack of efficacy, cited by 84 of 281 (30%). Gender, disability, and disease duration were identified as factors influencing interruption of IFNbeta therapy.

      Related collections

      Author and article information

      Journal
      12939437

      Comments

      Comment on this article